Claims for Patent: 4,499,901

Summary for Patent: 4,499,901

Title:	Retreated sensing electrode
Abstract:	An improved sensing electrode assembly for testing for a constituent in blood is provided. An electrode assembly exhibits a decreased time to reach stable operation by virtue of having the assembly pretreated by applying thereto a liquid containing blood derived albumin.
Inventor(s):	Chang; Joseph J. (Tampa, FL), Ramsey, III; Maynard (Tampa, FL)
Assignee:	Critikon, Inc. (Tampa, FL)
Application Number:	06/509,500
Patent Claims:	1. In an electrode assembly for insertion into a living animal to continuously monitor blood gas concentration, which assembly includes an electrode and a hydrophilic polymer membrane covering said electrode, wherein said membrane is hydrophilic substantially throughout its thickness, the improvement which comprises: said covering membrane being pretreated by having applied thereto a liquid solution comprising blood derived albumin, said pretreated membrane than being sterilized; and said electrode assembly exhibiting a lower T.sub.S than an assembly having an untreated membrane. 2. The electrode assembly of claim 1 wherein the T.sub.S is less than six hours. 3. The electrode assembly of claim 1 wherein said liquid solution is an aqueous solution. 4. The electrode assembly of claim 1 wherein said liquid solution is a solution of essembly pure blood derived albumin. 5. The electrode assembly of claim 4 wherein said blood derived albumin is human blood derived albumin. 6. The electrode assembly of claim 1 wherein said liguid solution is a solution of blood derived proteins. 7. The electrode assembly of claim 6 wherein said blood derived proteins are human blood derived proteins. 8. The electrode assembly of claim 1 wherein said liquid solution is blood serum. 9. The electrode assembly of claim 8 wherein said blood serum is human blood serum. 10. A method for decreasing the T.sub.S of an electrode assembly for insertion in a living animal to continuously monitor blood gas concentration, which assembly includes an electrode and a hydrophilic polymer membrane covering said electrode, wherein said membrane is hydrophilic substantially throughout its thickness, comprising the steps: pretreating said electrode by applying to said membrane a liquid solution comprising blood derived albumin and then sterilizing said electrode, whereby the T.sub.S of said electrode assembly is substantially lower than an assembly having an untreated membrane. 11. The method of claim 10 wherein said liquid is applied by immersing said electrode in said liquid for at least 10 minutes. 12. The method of claim 11 wherein said electrode is immersed in said liquid for at least one hour. 13. The method of claim 10 wherein said electrode is dried after said solution is applied. 14. The method of claim 13 wherein said electrode is sterilized after it is dried. 15. The method of claim 13 wherein silicone is applied to said electrode prior to drying.

Details for Patent 4,499,901

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Grifols Therapeutics Llc	ALBUKED, PLASBUMIN-20, PLASBUMIN-25, PLASBUMIN-5	albumin (human)	For Injection	101138	10/21/1942		2040-01-28
Baxalta Us Inc.	BUMINATE, FLEXBUMIN	albumin (human)	Injection	101452	03/03/1954		2040-01-28
Csl Behring Ag	ALBURX	albumin (human)	Injection	102366	07/23/1976		2040-01-28
Grifols Biologicals Llc	ALBUTEIN	albumin (human)	Injection	102478	08/15/1978		2040-01-28